Intrinsic Value of S&P & Nasdaq Contact Us

Enzo Biochem, Inc. ENZ NYSE

NYSE • Healthcare • Medical - Diagnostics & Research • US • USD

SharesGrow Score
37/100
0/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Stock Statistics — ENZ

Enzo Biochem, Inc. (ENZ) has a market capitalization of $16.44M and trades at $0.31. The 52-week range is 0.252-1.275.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of -0.6, Earnings Per Share (EPS) of $-0.51, annual revenue of $31.91M.

The stock has a beta of 1.16, a last dividend of $0.4000, operates in the Healthcare sector.

Trading Data
Current Price$0.31
52-Week Range0.252-1.275
Volume4.12M
Avg Volume (30D)348.83K
Market Cap$16.44M
Beta (1Y)1.16
Last Dividend$0.4000
Company
IPO Date1980-06-12
Employees125
CEOKara Cannon
CountryUS
ExchangeNYSE
CurrencyUSD
ISINUS2941001024
CUSIP294100102
Income (Latest Year)
Revenue$31.91M
Gross Profit$14.63M
EBITDA$-8.35M
Operating Income$-9.82M
Net Income$-26.08M
EPS$-0.51
EPS Diluted$-0.51
Shares Outstanding$50.9M
Balance Sheet (Latest Year)
Total Assets$85.76M
Current Assets$70.03M
Cash & ST Investments$52.37M
Total Liabilities$29.65M
Total Debt$3.51M
Net Debt$-48.86M
Total Equity$56.11M
Debt / Equity0.06
Valuation Ratios
P/E Ratio-0.6
P/S Ratio0.52
P/B Ratio0.29
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message